Key result
Pre-eclampsia acts as an immuno-cardiovascular disorder driven by inflammation, endothelial injury, and coagulation dysfunction.
Answers are grounded in this paper and cite their sources.
This review provides a comprehensive framework for understanding the pathophysiology of pre-eclampsia as an integrated immuno-cardiovascular disorder characterized by immune dysregulation, endothelial dysfunction, and thromboinflammation.
Pre-eclampsia is a complex multisystem hypertensive disorder of pregnancy and a leading cause of maternal and perinatal morbidity and mortality worldwide. Increasing evidence suggests that the condition extends beyond abnormal placentation and represents an integrated immuno-cardiovascular disorder characterized by immune dysregulation, endothelial dysfunction, thromboinflammation, and cardiovascular maladaptation. This narrative review examines the interconnected mechanisms linking cytokine-mediated inflammation, endothelial injury, coagulation abnormalities, and maternal cardiovascular instability in pre-eclampsia. A structured literature search of major biomedical databases was conducted to identify relevant experimental, clinical, and translational studies addressing inflammatory cytokines, angiogenic imbalance, endothelial dysfunction, thrombosis, biomarkers, and therapeutic strategies in pre-eclampsia. The review highlights the central roles of pro-inflammatory mediators, including tumor necrosis factor-α, interleukin-6, interleukin-17, and interferon-γ, in promoting oxidative stress, vascular inflammation, and endothelial dysfunction. Particular attention is given to the development of an immunothrombotic environment, defined as the pathological interaction between immune activation and coagulation pathways that promotes thrombosis and vascular injury. The review also critically evaluates the contribution of antiangiogenic factors, platelet activation, impaired fibrinolysis, and cardiovascular remodeling to maternal disease progression. In addition, current and emerging therapeutic approaches targeting inflammatory, endothelial, angiogenic, and thrombotic pathways are discussed, together with their translational potential and clinical limitations. By integrating immunological, vascular, hematological, and cardiovascular perspectives, this review provides a comprehensive framework for understanding the pathophysiology of pre-eclampsia and identifies important knowledge gaps for future investigation.
No takes yet. Share an insight, caveat, or question.
Emmanuel Ifeanyi Obeagu (2026) conducted a review in Pre-eclampsia. Pre-eclampsia is an integrated immuno-cardiovascular disorder driven by cytokine-mediated inflammation, endothelial injury, and coagulation abnormalities leading to maternal cardiovascular instability.
Synapse has enriched 10 related papers. Consider them for comparative context: